AstraZeneca
NEWS
Astra signed a licensing deal with Mereo BioPharma to out license the oral inhibitor of neutrophil elastase to the smaller Mereo.
The former Biogen CEO is making waves at his new venture, Vir Biotechnology.
WuXi AppTec, a China CRO/CMO, will acquire ResearchPoint Global, of Texas, a global clinical-stage contract research company, to extend the reach of its own clinical CRO coverage.
ADC Therapeutics announced it had raised $200M through an oversubscribed private placement.
Vivek Ramaswamy’s parent company, Roivant Sciences, inked a development deal with Astra.
The lawsuit was filed on behalf of members of the American military who were injured or killed by attacks between 2005 and 2009
JOBS
IN THE PRESS